Program details
-
BS1 Breakfast symposium 1 Sponsored by Lilly
Chair(s): Sang Ah Chang
Friday 20 October, 08:00~09:00
Room 1 (3F) -
-
BS1
Ja Young Jeon Ajou University, Korea - Treatment of T2D patients considering renal function
-
-
BS2 Breakfast symposium 2 Sponsored by Ildong Pharmaceutical
Chair(s): Jioh Mok
Friday 20 October, 08:00~09:00
Room 2 (3F) -
-
BS2
Yong-ho Lee Yonsei University, Korea - Q-Tern, SGLT2 inhibitor + DPP4 inhibitor combination therapy: efficacy, safety and patients compliance
-
-
BS3 Breakfast symposium 3 Sponsored by MSD
Chair(s): Eun Gyoung Hong
Friday 20 October, 08:00~09:00
Room 3 (3F) -
-
BS3
Kyung Ae Lee Jeonbuk National University, Korea - How to find optimal combination therapy for patients with type 2 diabetes
-
-
BS4 Breakfast symposium 4 Sponsored by Celltrion
Chair(s): Sang-Wook Kim
Saturday 21 October, 08:00~09:00
Room 1 (3F) -
-
BS4
Chang Hee Jung University of Ulsan, Korea - What should we consider when choosing DPP-4 inhibitors for elderly patients?
-
-
BS5 Breakfast symposium 5 Sponsored by JW Pharmaceutical
Chair(s): Heung Yong Jin
Saturday 21 October, 08:00~09:00
Room 2 (3F) -
-
BS5
Young Sang Lyu Chosun University, Korea - Cutting edge care of pitavastatin with ezetimibe combination therapy
-
-
LS1 Luncheon symposium 1 Sponsored by Daewoong Pharmaceutical
Chair(s): Sung-Dae Moon
Friday 20 October, 12:10~13:00
Room 1 (3F) -
-
LS1
Soo Lim Seoul National University, Korea - What’s new? SGLT2 inhibitor's enhanced glucose lowering effect
-
-
LS2 Luncheon symposium 2 Sponsored by LG Chem
Chair(s): Young Sun Hong
Friday 20 October, 12:10~13:00
Room 2 (3F) -
-
LS2
Hye Jin Yoo Korea University, Korea - Combination of DPP-4i and SGLT-2i: new insights from recent clinical trials
-
-
LS3 Luncheon symposium 3 Sponsored by Dong-A ST
Chair(s): Bon Jeong Ku
Friday 20 October, 12:10~13:00
Room 3 (3F) -
-
LS3
Jun Hwa Hong Eulji University, Korea - What's new in drug treatment of diabetes steps
-
-
LS4 Luncheon symposium 4 Sponsored by Handok
Chair(s): Chul Sik Kim
Friday 20 October, 12:10~13:00
Room 4 (2F) -
-
LS4
Sun Joon Moon Sungkyunkwan University, Korea - A new choice for diabetes treatment: advanced hybrid closed loop
-
-
LS5 Luncheon symposium 5 Sponsored by BI-LLY
Chair(s): Yeon Ah Sung
Saturday 21 October, 12:00~13:00
Room 1 (3F) -
-
LS5
Seung-Hwan Lee The Catholic University of Korea, Korea - Optimal combination use of SGLT2i and DPP4i
-
-
LS6 Luncheon symposium 6 Sponsored by Chongkundang
Chair(s): Kyung Ah Han
Saturday 21 October, 12:00~13:00
Room 2 (3F) -
-
LS6
Yun Kyung Cho University of Ulsan, Korea - The newest combination therapy: SGLT2I & TZD
-
-
LS7 Luncheon symposium 7 Sponsored by Novo Nordisk
Chair(s): Tae Keun Oh
Saturday 21 October, 12:00~13:00
Room 3 (3F) -
-
LS7
Jang Won Son The Catholic University of Korea, Korea - The holistic management with GLP-1RA in real practice
-
-
LS8 Luncheon symposium 8 Sponsored by AstraZeneca
Chair(s): Kyungwan Min
Saturday 21 October, 12:00~13:00
Room 4 (2F) -
-
LS8
Hae Jin Kim Ajou University, Korea - Ideal clinical approach to use of dapagliflozin + sitagliptin fixed-dose combination for T2D patients
-
Korean Diabetes Association-
- (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
- Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
- Business Registration Number: 106-82-31108 | Name of Representative: Kyu-Chang Won
- Congress Secretariat (Planbear)
-
- #1101, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
- Tel: +82-2-6734-1011/1012/1013 E-mail: icdm@diabetes.or.kr
copyright© By Korean Diabetes Association.
All rights reserved.
Businuess Registration Number: 106-82-31108
Name of Representative : Kyu-Chang Won
